跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glixfort - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glixfort
Approved
STANDARD
Glixfort
Acme Formulation Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d7fc8afa512c4547
Company
Acme Formulation Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
d7fc8afa512c4547
Drug Approval Philippines Name
Glixfort
Product Name
Glixfort
Registration Number
DRP-13703
Brand Name
Glixfort
Generic Name
Metformin hydrochloride + Glibenclamide
Dosage Form
Tablet
Dosage Strength
500 mg/5 mg
Manufacturer
Acme Formulation Pvt. Ltd.
Trader
India
Distributor
Ambica International Corporation
Issuance Date
29 March 2023
Expiry Date
29 March 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d7fc8afa512c4547
Type
Standard
Back to Philippines FDA Approvals